The Association for Pathology Informatics gratefully acknowledges the financial support given by our Institutional Sponsors.
Cleveland Clinic's Pathology and Laboratory Medicine Institute is the largest volume hospital laboratory in the state of Ohio and the 15th largest in the United States, with approximately 1,300 dedicated employees and performing more than 12 million tests annually. The Institute provides crucial pathology and laboratory testing services to patients at Cleveland Clinic, the Cleveland Clinic family health centers and externally through Cleveland Clinic Laboratories.
The clinical programs of the Department offer advanced services in all subspecialties of anatomic, clinical, surgical, and molecular pathology. Our faculty members have authored numerous textbooks and scientific papers. The Department has had distinguished residency and fellowship programs since 1892 and teaching residents, medical students, and Ph.D students remains an important commitment.
The research programs of the Department span basic, translational, and clinical areas. The Department is home to more than 60 research faculty members, 100 postdoctoral fellows and 50 Ph.D. candidates. In 2012 we ranked 5th among Pathology Departments in the United States in our NIH research support and our graduate program in Pathobiology and Molecular Medicine is one of the most active in the country.
While there is a range of research interests, there are concentrations in neurodegenerative diseases, stem cell biology, and cancer biology (See Associated Research Centers). Our basic science faculty members concentrate on cell biology and have made major contributions to basic mechanisms of cell division, cell migration, axonal transport, renal development and other areas.
The mission of the East Carolina University Department of Pathology & Laboratory Medicine, in conjunction with Vidant Medical Center, is to improve the health and well being of the citizens of eastern North Carolina and beyond by (1) delivering the highest quality pathology services, (2) providing exemplary education for medical students, residents, and other health care professionals, and (3) creating new knowledge through research.
Geisinger research pursues an ambitious agenda with the long-term goal of directly impacting the health of our patients, our community and health care as a whole. A unique aspect of Geisinger research is that, unlike traditional academic approaches, scientists are integrally connected to the clinical enterprise. This facilitates interdisciplinary team-based collaborations to address clinically relevant questions.
Our Department’s main mission of clinical patient care is supported by 46 senior staff pathologists and clinical scientists who are members of the Henry Ford Medical Group. They are complemented by 710 technical staff who manage over 11 million clinical laboratory tests and over 150,000 anatomic pathology specimen examinations. Clinical volumes are enhanced by a robust Outreach service – the Henry Ford Medical Laboratories that serve local and international clients.
The mission of the Department of Pathology and Genomic Medicine is to provide high quality, cost-effective patient care in an environment that fosters the advancement of medical knowledge. We provide outstanding diagnostic and therapeutic services and information, develop new approaches to the diagnosis and treatment of disease, and educate physicians, scientists, and technologists using state-of-the-art advanced equipment. The faculty in the Department of Pathology and Genomic Medicine are internationally renowned with expertise in major subspecialty areas of both anatomic pathology and clinical pathology.
Our vision is to provide patients a better chance of cure by defining their disease and optimizing treatment, while offering a superior quality of life and preserving their dignity.
We were the first major medical center to establish a fully integrated pathology department combining the various arms of testing—anatomical, clinical, molecular/genetic, and cytological.
The strong rapport between pathology and clinical services facilitates our advances in understanding and treating disease. Many collaborative research opportunities exist intra- and interdepartmentally. Specimens that most departments may come across only once every five years or more are seen on a monthly basis here.
We strive to integrate what we learn through our clinical laboratory services, cytology, surgical, and molecular pathology to better guide patient care. This approach will improve treatment efficacy and clinical outcomes.
Memorial Sloan Kettering Cancer Center - the world's oldest and largest private cancer center - has devoted more than 130 years to exceptional patient care, innovative research, and outstanding educational programs. Today, we are one of 47 National Cancer Institute - designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side by side with clinical studies and treatment.
The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available as we work to discover more-effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan Kettering has an impact on cancer treatment and biomedical research around the world.
Mission: To improve the diagnosis, treatment and basic understanding of human disease by clinical service, education and research.
Research: Advance basic science, translational and clinical research in pathology and related fields;
Patient Care: Provide pathology diagnostic services and blood products of the highest quality;
Education: Teach medical and graduate students, residents and fellows, and foster the development of leaders in pathology and related fields;
Citizenship: Contribute to the success of Stanford University Medical Center and Stanford University, and to the well being of all those people and communities we serve.
Our mission is to advance health and wellness across the life span for the people of New York and the world through the education of tomorrow’s leaders in health care and biomedical sciences, innovative research and outstanding clinical care.
• Attract the most promising individuals and support their development
• Enhance our intellectual and technological environment to foster exceptionally creative science and education
• Develop and maintain excellent clinical programs to provide outstanding care
• Cultivate excellence, collegiality, and diversity
• Observe the highest standards of ethics, integrity, professionalism, and humanism
• Apply advances in science, medicine, and education to the betterment of humanity
The Division of Pathology and Laboratory Medicine is the integral bridge between clinical care and basic science at The University of Texas MD Anderson Cancer Center. It plays an essential role in the institution's mission to improve patient care and eliminate cancer and allied diseases as a significant problem in Texas, the United States and the world.
The division comprises three clinical departments and one research department. The clinical departments are CLIA certified and CAP accredited.
The division and the departments serve MD Anderson patients, Outreach and Physician Network patients and clinical staff. The faculty engages in programmatic and interdisciplinary basic, clinical and translational research.
As an investigative discipline, pathology researchers identify the origins of disease and contribute to strategies for its treatment. As a medical discipline, pathologists engage in patient care as consultants and innovators for biochemical, molecular, and cell biology tests that guide diagnostic and treatment choices. Through these roles, the Department of Pathology and Laboratory Medicine at UCLA assists doctors and patients in making optimal decisions based on the latest diagnostic studies, using state-of-the-art instrumentation. Each month, approximately 50,000 clinical tests, and 1,500 biopsy and cytology cases, are analyzed to guide the care of patients in UCLA Health System, and through our referral network regionally and nationally.
The UAB Department of Pathology provides extensive clinical services and teaching while maintaining large and productive research programs. Currently, the Department has over $25 million per year in extramural research funding and our clinical services, including inpatient, outpatient and outreach, completes over 6 million procedures per year. The Division of Informatics is its 6th and newest unit, with the goal of assisting in developing a Precision Medicine component contributing to training, research and service programs that have achieved national and international recognition.
The Department of Pathology & Laboratory Medicine (DPLM), Cumming School of Medicine is affiliated with Calgary Laboratory Services (CLS), a wholly owned subsidiary of Alberta Health Services - Calgary Zone. The Department of Pathology & Laboratory Medicine (DPLM) comprised of medical and scientific staff for Calgary Laboratory Services (CLS). The department has 6 CLS Clinical Sections and has 82 primary clinical MD appointees and 13 clinical PhD scientists. There are 28 members with University of Calgary and 67 members with Clinical Faculty appointments.
Our Medical/Scientific staff are located at all 5 acute-care hospital sites, at CLS’ central laboratory facility the Diagnostic & Scientific Centre (DSC), and at the University of Calgary Health Sciences Centre (HSC), Heritage Medical Research Building (HMRB), and Health Research Innovation Centre (HRIC).
The Department of Pathology at the University of California, San Francisco, aims to achieve the highest standards in patient care, research, and education. The Department provides diagnostic pathology services in a wide variety of areas, with the most modern available technologies and highly trained subspecialists who are recognized nationally and internationally for their expertise.
The Department’s research programs are diverse, and interface with a wealth of basic and translational research programs that are a hallmark of UCSF.
The Department is dedicated to training the next generation of practicing and experimental pathologists. To capitalize on the unique position of the Pathology Department's relationships with clinical and basic research departments, our research effort has a strong translational focus, and is home to federally funded investigator-initiated clinical trials – a true manifestation of a bench to bedside approach of medical investigations. The major theme of our Research Section is a unique fusion of molecular epidemiology and pathology. A novel Section of Transdisciplinary Pathology helps integrate research throughout the College of Medicine and the other Health Science Colleges. The Department hosts Core Laboratories in advanced tissue imaging techniques and research histology including immunohistochemistry, in-situ hybridization, tissue microarrays and laser capture micro-dissection. Together with Cancer Center, we house a Tissue Biorepository and will be developing shared virtual tissue banks with other academic centers.
The goals of the Department of Pathology are inseparable from the goals of the Health System: leadership in education, research, and service. In addition, by virtue of its position, the Department is dedicated to serve in a unifying role within the university medical community.
Education. Research. Service. Unifying role.
The Department of Pathology and Laboratory Medicine, one of the largest departments in the School of Medicine at Penn, is considered both a basic science as well as clinical department and its 100+ faculty members are integrated into both areas. Clinically oriented faculty members have their primary base at four institutions: Hospital of the University of Pennsylvania (HUP), Presbyterian Medical Center (PMC), Pennsylvania Hospital (PAH) and Children’s Hospital of Philadelphia (CHOP). Research faculty are located on the University of Pennsylvania School of Medicine campus.
The University of Pittsburgh's Department of Biomedical Informatics (DBMI) brings together a diverse group of faculty committed to improving biomedical research and clinical care through the application of innovative technologies. Currently funded projects explore areas such as genomic and proteomic data mining, natural language processing, machine learning, and biosurveillance.
A dynamic and rapidly evolving field, Pathology plays a pivotal role in diagnosis, research, and monitoring treatment. The Department of Pathology at the University of Pittsburgh School of Medicine exemplifies the field's complex nature and incorporates Pathology's dramatic new developments in molecular biology and diagnostic biotechnology.
With 91 full-time primary faculty, 31 dual-appointment faculty, 92 voluntary faculty and 41 residents and fellows in training, the Keck USC Department of Pathology is one of the largest pathology departments in the United States. The Department provides diagnostic laboratory services for the LAC+USC Medical Center, the USC University and Norris Cancer Hospitals, the Doheny Eye Institute, and through its reference laboratories, the USC Clinical Laboratory Group.
Wake Forest School of Medicine (WFSM) occupies a firm position among the best medical schools in the United States. The desire to teach excellence in clinical medicine, promote strong clinical and basic research, render exemplary patient care, and stress service to the community has continued as an integral part of Wake Forest Baptist Medical Center, a leading research and teaching hospital.
Wake Forest Baptist Medical Center is a preeminent, internationally recognized academic medical center of the highest quality with balanced excellence in patient care, research and education.
The Department of Pathology at Yale, one of the first departments organized at Yale School of Medicine, is dedicated to continuing its long and distinguished tradition of world-renowned clinical care, cutting-edge scientific research, and rigorous training of the next generation of pathologists to be leaders in their field. With robust research investigations, teaching programs and exceptional clinical patient care, we are able to bring new knowledge and innovative therapeutic approaches to our patients and to medicine. Our dedication to excellence in both the clinical and the academic arenas is paramount to our mission as a Department and to our goal of advancing patient care through expert diagnostics and novel therapeutics.